Canagliflozin for the treatment of adults with Type 2 diabetes

ISSN： 1758-1907

Source： Diabetes Management, Vol.3, Iss.4, 2013-07, pp. : 343-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition with Canagliflozin in Type 2 Diabetes Mellitus

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 11, Iss. 3, 2013-09 ,pp. : 203-206

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Microalbuminuria in Patients with Type 2 Diabetes Mellitus

By Jerums G. MacIsaac R.J.

Treatments in Endocrinology, Vol. 1, Iss. 3, 2002-03 ,pp. : 163-173

Adis International

Access to resources Recommend Favorite

Metabolic effects of interventions to increase exercise in adults with type 2 diabetes

By Conn V. Hafdahl A. Mehr D. LeMaster J. Brown S. Nielsen P.

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 913-921

Springer Publishing Company

Access to resources Recommend Favorite

Marked temporal increase in the incidence of type 1 and type 2 diabetes among young adults in Finland

By Lammi N.

Diabetologia, Vol. 51, Iss. 5, 2008-05 ,pp. : 897-899

Springer Publishing Company

Access to resources Recommend Favorite

Modulation of Monoaminergic Neural Circuits: Potential for the Treatment of Type 2 Diabetes Mellitus

By Pijl H. Meinders E.A.

Treatments in Endocrinology, Vol. 1, Iss. 2, 2002-02 ,pp. : 71-78

Adis International

Access to resources Recommend Favorite